Metroplex Clinical Research   Report issue

For profit Phase 1
Founded: Dallas TX United States (1984)

Organization Overview

First Clinical Trial
2011
NCT01339481
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Metroplex Clinical Research Center | Stanley Cohen